In our opinion, there is a possibility that TNF-α serum levels may become a marker used for clinical verification in the case of problematic differentiation (UF or different tumor) [30], or to determine the risk of clinical symptoms, as can be partially done with endometriosis [209]. This evidence concerns the gene TNF and endometriosis.